Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for the Fourth Quarter and Full Year 2022

Go back to Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for the Fourth Quarter and Full Year 2022
(NASDAQ: FULC) Delayed: 3.45 -0.1 (2.82%)
Previous Close $3.55    52 Week High
Open $3.56    52 Week Low
Day High $3.54    P/E N/A 
Day Low $3.43    EPS
Volume 1,344,044